RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+30.49%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.11B
AUM Growth
+$1.11B
(+27%)
Cap. Flow
+$41.6M
Cap. Flow
% of AUM
3.75%
Top 10 Holdings %
Top 10 Hldgs %
76.43%
Holding
31
New
9
Increased
4
Reduced
3
Closed
4
Top Buys
| 1 |
KALA BIO
KALA
|
$48.3M |
| 2 |
Insmed
INSM
|
$22.6M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$22.3M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$20.7M |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$10.6M |
Top Sells
| 1 |
Esperion Therapeutics
ESPR
|
$33.9M |
| 2 |
RDUS
Radius Health, Inc.
RDUS
|
$22.5M |
| 3 |
Neurogene
NGNE
|
$19.6M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$16.9M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$16.9M |
Sector Composition
| 1 | Healthcare | 95.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Protara Therapeutics
TARA
$120M
| $2.68M | 0.24% | 1,337,462 | – | – |
|
27
Akebia Therapeutics
AKBA
$833M
| – | – | -836,337 | Closed | -$12M |
|
|
28
Esperion Therapeutics
ESPR
$448M
| – | – | -731,531 | Closed | -$33.9M |
|
|
29
Neurogene
NGNE
$264M
| – | – | -1,396,071 | Closed | -$19.6M |
|
|
RDUS
30
DELISTED
Radius Health, Inc.
RDUS
| – | – | -497,157 | Closed | -$22.5M |
|